EX-99.2 3 dex992.htm CRANE CO. QUARTERLY FINANCIAL DATA SUPPLEMENT Crane Co. Quarterly Financial Data Supplement

Exhibit 99.2

CRANE CO.

Income Statement Data

(in thousands, except per share data)

 

     Three Months Ended
June 30,
    Six Months Ended
June 30,
 
     2009     2008     2009     2008  

Net Sales:

        

Aerospace & Electronics

   $ 146,995      $ 165,928      $ 298,942      $ 324,379   

Engineered Materials

     41,772        72,937        79,925        155,710   

Merchandising Systems

     73,331        116,233        145,026        229,737   

Fluid Handling

     263,083        301,100        529,573        589,600   

Controls

     20,310        37,284        47,163        72,924   
                                

Total Net Sales

   $ 545,491      $ 693,482      $ 1,100,629      $ 1,372,350   
                                

Operating Profit:

        

Aerospace & Electronics

   $ 19,099      $ 18,487      $ 36,331      $ 34,482   

Engineered Materials

     4,580        8,100        6,067        19,754   

Merchandising Systems

     6,675        17,339        9,655        31,477   

Fluid Handling

     27,059        46,556        63,826        91,318   

Controls

     (1,731     3,547        (1,317     4,847   

Corporate

     (10,190     (7,758     (31,186 ) *      (20,258
                                

Total Operating Profit

     45,492        86,271        83,376        161,620   

Interest Income

     465        2,883        1,308        5,167   

Interest Expense

     (6,780     (6,678     (13,549     (13,183

Miscellaneous- Net

     529        1,342        2,240        1,761   
                                

Income Before Income Taxes

     39,706        83,818        73,375        155,365   

Provision for Income Taxes

     11,901        25,098        22,141        48,178   
                                

Net income before allocation to noncontrolling interests

     27,805        58,720        51,234        107,187   

Less: Noncontrolling interest in subsidiaries’ earnings (losses)

     38        (289     157        (200
                                

Net income attributable to common shareholders

     27,767        59,009        51,077        107,387   
                                

Share Data:

        

Earnings per Diluted Share

   $ 0.47      $ 0.97      $ 0.87      $ 1.77   
                                

Average Diluted Shares Outstanding

     58,728        60,581        58,643        60,812   

Average Basic Shares Outstanding

     58,459        59,707        58,458        59,911   

Supplemental Data:

        

Cost of Sales

   $ 369,537      $ 455,647      $ 751,546      $ 908,178   

Selling, General & Administrative

     130,462        151,564        265,707        302,552   

Depreciation and Amortization **

     14,779        14,712        29,832        29,695   

Stock-Based Compensation Expense

     2,374        3,370        4,436        6,985   

 

* Includes a charge of $7.25 million related to the settlement of a lawsuit brought against the Company by a customer alleging failure of our fiberglass-reinforced plastic material.
** Amount included within cost of sales and selling, general & administrative costs.


CRANE CO.

Condensed Balance Sheets

(in thousands)

 

     June 30,
2009
   December 31,
2008

ASSETS

     

Current Assets

     

Cash and Cash Equivalents

   $ 232,974    $ 231,840

Accounts Receivable, net

     319,812      334,263

Current Insurance Receivable - Asbestos

     35,300      41,300

Inventories, net

     333,660      349,926

Other Current Assets

     66,785      63,911
             

Total Current Assets

     988,531      1,021,240

Property, Plant and Equipment, net

     289,807      290,814

Long-Term Insurance Receivable - Asbestos

     230,886      260,660

Other Assets

     441,217      420,542

Goodwill

     763,026      781,232
             

Total Assets

   $ 2,713,467    $ 2,774,488
             

LIABILITIES AND EQUITY

     

Current Liabilities

     

Notes Payable and Current Maturities of Long-Term Debt

   $ 805    $ 16,622

Accounts Payable

     143,278      182,147

Current Asbestos Liability

     91,000      91,000

Accrued Liabilities

     225,350      246,915

Income Taxes

     5,411      1,980
             

Total Current Liabilities

     465,844      538,664

Long-Term Debt

     399,436      398,479

Long-Term Deferred Tax Liability

     24,887      22,971

Long-Term Asbestos Liability

     791,187      839,496

Other Liabilities

     224,496      229,057

Total Equity

     807,617      745,821
             

Total Liabilities and Equity

   $ 2,713,467    $ 2,774,488
             


CRANE CO.

Condensed Statements of Cash Flows

(in thousands)

 

     Three Months Ended
June 30
    Six Months Ended
June 30
 
     2009     2008     2009     2008  

Operating Activities:

        

Net income attributable to common shareholders

   $ 27,767      $ 59,009      $ 51,077      $ 107,387   

Noncontrolling interest in subsidiaries’ earnings (losses)

     38        (289     157        (200
                                

Net income before allocations to noncontrolling interests

     27,805        58,720        51,234        107,187   

Gain on divestiture

     —          (932     —          (932

Depreciation and amortization

     14,779        14,712        29,832        29,695   

Stock-based compensation expense

     2,374        3,370        4,436        6,985   

Deferred income taxes

     (5,910     5,768        2,784        11,865   

Cash provided by (used for) operating working capital

     6,997        (16,454     (20,622     (46,288

Other

     (499     (5,263     (9,390     (2,401
                                

Subtotal

     45,546        59,921        58,274        106,111   

Asbestos related payments, net of insurance recoveries

     (15,191     (14,553     (12,535 ) *      (16,614
                                

Total provided by operating activities

     30,355        45,368        45,739        89,497   
                                

Investing Activities:

        

Capital expenditures

     (7,458     (11,321     (17,432     (20,401

Proceeds from disposition of capital assets

     622        48        2,325        444   

Payment for acquisition, net of cash acquired

     —          (47     —          (132

Proceeds from divestiture

     —          1,320        —          2,106   
                                

Total used for investing activities

     (6,836     (10,000     (15,107     (17,983
                                

Financing Activities:

        

Dividends paid

     (11,696     (10,761     (23,384     (21,556

Reacquisition of shares on open market

     —          —          —          (40,000

Stock options exercised - net of shares reacquired

     884        5,535        247        9,091   

Excess tax benefit from stock-based compensation

     —          793        —          900   

Change in short-term debt

     (6,089     (5,995     (15,405     3,042   
                                

Total used for financing activities

     (16,901     (10,428     (38,542     (48,523
                                

Effect of exchange rate on cash and cash equivalents

     16,041        1,880        9,044        15,187   
                                

Increase in cash and cash equivalents

     22,659        26,820        1,134        38,178   

Cash and cash equivalents at beginning of period

     210,315        294,728        231,840        283,370   
                                

Cash and cash equivalents at end of period

   $ 232,974      $ 321,548      $ 232,974      $ 321,548   
                                

 

* Includes a $14.5 million insurance settlement receipt from the Highlands Insurance Company.


CRANE CO.

Order Backlog

(in thousands)

 

     June 30,
2009
   March 31,
2009
   December 31,
2008
   June 30,
2008

Aerospace & Electronics

   $ 383,335    $ 396,393    $ 418,382    $ 417,883

Engineered Materials

     9,135      6,924      6,942      11,892

Merchandising Systems

     19,955      18,822      23,407      35,708

Fluid Handling*

     256,467      275,660      302,653      297,937

Controls

     28,026      26,667      30,509      41,633
                           

Total Backlog

   $ 696,918    $ 724,466    $ 781,893    $ 805,053
                           

 

* Includes Order Backlog of $41.8 million in June 2009, $46.5 million in March 2009 and $57.0 million in December 2008 pertaining to the 2008 acquisitions of Delta and Krombach.


CRANE CO.

Non-GAAP Financial Measures

(in thousands)

 

     Three Months Ended
June 30,
    Six Months Ended
June 30,
    Percent
Change
June 30,

2009
    Percent
Change
June 30,

2009
       
     2009     2008     2009     2008     Three
Months
    Six
Months
   
INCOME ITEMS               

Net Sales

   $ 545,491      $ 693,482      $ 1,100,629      $ 1,372,350      -21.3   -19.8  

 

Operating Profit

     45,492        86,271        83,376        161,620         

 

Special Items impacting Operating Profit:

              

Lawsuit Settlement - Pre-Tax (a)

     (500     —          7,250        —           

 

Restructuring Charges - Pre-Tax (b)

     2,295        —          1,847        —           

 

Environmental Reimbursement - Pre-Tax (d)

     —          (4,444     —          (4,444      
                                      

Operating Profit before Special Items

   $ 47,287      $ 81,827      $ 92,473      $ 157,176      -42.2   -41.2  
                                      

Percentage of Sales

     8.7     11.8     8.4     11.5      
                                         2009 Full Year
Guidance
 
                                         Low     High  

Net Income Attributable to Common Shareholders

   $ 27,767      $ 59,009      $ 51,077      $ 107,387          $ 103,250      $ 121,000   

Per Share

   $ 0.47      $ 0.97      $ 0.87      $ 1.77          $ 1.75      $ 2.05   

 

Special Items impacting Net Income Attributable to Common Shareholders:

                

Lawsuit Settlement - Net of Tax (a)

     (325     —          4,713        —              4,713  (a)      4,713  (a) 

Per Share

   $ (0.01     —        $ 0.08        —            $ 0.08      $ 0.08   

 

Restructuring Charges (Gains) - Net of Tax

     1,692 (b)      —          1,402 (b)      —              5,850  (c)      5,850  (c) 

Per Share

   $ 0.03        —        $ 0.02        —            $ 0.10      $ 0.10   

Environmental Reimbursement - Net of Tax (d)

     —          (2,889     —          (2,889         —          —     

Per Share

     —          (0.05     —          (0.05         —          —     
                                                    

Net Income Attributable To Common Shareholders Before Special Items

   $ 29,134      $ 56,120      $ 57,192      $ 104,498      -48.1   -45.3   $ 113,813      $ 131,563   
                                                    

Per Share

   $ 0.50      $ 0.93      $ 0.98      $ 1.72          $ 1.93      $ 2.23   

 

(a) During the three months ended March 31, 2009, the Company recorded a charge for the settlement of a lawsuit brought against the Company by a customer alleging failure or our fiberglass-reinforced plastic material. During the three months ended June 30, 2009, the Company recorded additional insurance recoveries associated with the aforementioned settlement.
(b) Amounts represent restructuring charges in connection with the Restructuring Program.
(c) Amounts represent restructuring charges in connection with the Restructuring Program and integration costs associated with the Krombach acquisition.
(d) During the three months ended June 30, 2008, the Company recorded a $2.1 million reimbursement from the US Government and a $2.4 million reimbursement from a service provider, both related to environmental clean-up activities.

 

     June 30,
2009
    December 31,
2008
       
BALANCE SHEET ITEMS       

Notes Payable and Current Maturities of Long-Term Debt

   $ 805      $ 16,622     

Long-Term Debt

     399,436        398,479     
                  

Total Debt

     400,241        415,101     

Less: Cash and Cash Equivalents

     (232,974     (231,840  
                  

Net Debt

     167,267        183,261     

Equity

     807,617        745,821     
                  

Net Capitalization

   $ 974,884      $ 929,082     
                  

Percentage of Net Debt to Net Capitalization

     17.2     19.7  
     Three Months Ended
June 30,
    Six Months Ended
June 30,
 
     2009     2008     2009     2008  
CASH FLOW ITEMS         

Cash Provided from Operating Activities before Asbestos - Related Payments

   $ 45,546      $ 59,921      $ 58,274      $ 106,111   

Asbestos Related Payments, Net of Insurance Recoveries

     (15,191     (14,553     (12,535 ) *      (16,614
                                

Cash Provided from Operating Activities

     30,355        45,368        45,739        89,497   

Less: Capital Expenditures

     (7,458     (11,321     (17,432     (20,401
                                

Free Cash Flow

   $ 22,897      $ 34,047      $ 28,307      $ 69,096   
                                

 

* Includes a $14.5 million insurance settlement receipt from the Highlands Insurance Company.

Certain non-GAAP measures have been provided to facilitate comparison with the prior year.

The Company reports its financial results in accordance with U.S. generally accepted accounting principles (GAAP). However, management believes that non-GAAP financial measures which exclude certain non-recurring items present additional useful comparisons between current results and results in prior operating periods, providing investors with a clearer view of the underlying trends of the business. Management also uses these non-GAAP financial measures in making financial, operating, planning and compensation decisions and in evaluating the Company’s performance. In addition, Free Cash Flow provides supplemental information to assist management and investors in analyzing the Company’s ability to generate positive cash flow. Non-GAAP financial measures, which may be inconsistent with similarly captioned measures presented by other companies, should be viewed in addition to, and not as a substitute for, the Company’s reported results prepared in accordance with GAAP.